U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT07547033) titled 'Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy' on Feb. 26.
Brief Summary: "Pancreatic cancer, especially pancreatic ductal adenocarcinoma, is one of the most serious and deadly cancers. Its outlook is very poor, with fewer than 10% of patients surviving five years after diagnosis. This is largely because the disease is often discovered at a late stage and because it frequently comes back even after surgery.
When the tumor is located in the head of the pancreas, the only treatment that can potentially cure the disease is a major operation called a pancreaticoduodenectomy, also known as the Whi...